Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Applied Proteomics Inc | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study is a pre-post two round, randomized controlled study design of PCPs randomly assigned to a control or 1 of 2 intervention arms.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | No Intervention | Control: not receiving any intervention | |
| Intervention 1 | Experimental | Receiving educational materials on a new diagnostic service |
|
| Intervention 2 | Experimental | Receiving educational materials on a new diagnostic service |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Educational materials on a new diagnostic service | Other | Educational materials on a new diagnostic service |
|
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Care | Difference in difference of combined diagnostic and treatment CPV domain scores, including colonoscopy referral rates, in post-intervention versus baseline comparing intervention and control groups among the three patient types. | 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Intervention Impact on Care | Difference in difference between the control and intervention groups in the overall quality of care for CRC screening and for adult primary prevention care measured by the combined and individual item CPV scores for the three patient types. | 8 weeks |
| Healthcare Utilization |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| John Peabody, MD, PhD | QURE Healthcare | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| QURE Healthcare | San Francisco | California | 94109 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Difference in health care utilization and/or costs in patients tested with SimpliPro Colon™ versus the control group. |
| 8 weeks |
| Diagnostic Method Comparison | Difference in recommendation of CRC evaluation with colonoscopy and/or flexible sigmoidoscopy, double barium enema, or CT colonography, including risk-level and urgency pre- and post-intervention, between intervention and control groups | 8 weeks |